MoneyWorks4Me

Alembic Pharmaceuticals informs about disclosure

17 Jun 2024 Evaluate
Alembic Pharmaceuticals has informed that the company has received the USFDA Final approval for Icatibant Injection 30 mg/3mL (10 mg/mL) Single dose prefilled syringe. This is the first peptide product approval from the USFDA received by the Company.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..